• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

RUSH, R1 Launch Innovation Lab to Drive Value-Based Care & Advanced Analytics

by Jasmine Pennic 08/05/2020 Leave a Comment

Rush University Medical Center Taps R1 for End-to-End Revenue Cycle Management, Innovation Lab

What You Should Know:

– Rush University System for Health (RUSH) and R1 RCM Inc. launches a joint Innovation Lab to deliver solutions to improve the quality of care for patients.

– The Innovation Lab is expected to commercialize its solutions beginning in 2021.


Rush University System for Health (RUSH) and R1 RCM Inc., a provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, announced the launch of a joint Innovation Lab to deliver solutions to improve the quality of care for patients on a national scale.

Innovation Lab to Drive Industry-Leading Quality and Patient Experience

By combining industry-leading care quality tools RUSH’s Center for Quality, Safety and Value Analytics has developed with R1’s platform, the Innovation Lab will deliver new and innovative solutions focused on value-based care and advanced analytics.

The Innovation Lab partnership brings together RUSH’s proven ability to develop unique, quality tools that help solve the new and changing standards of care along with R1’s technology-enabled, systematic operations that provide reliable improvements to the patient experience. Via the Innovation Lab, R1 will not only invest resources to develop new solution tools, but also make existing tools available to other health systems across the country.

Availability 

The Innovation Lab is expected to commercialize its solutions beginning in 2021.

“R1 is enabling RUSH’s mission to help improve the quality of care for all patients, be it at RUSH, or elsewhere,” said Dr. Ranga Krishnan, CEO of Rush University Health System. “RUSH has used technology as a part of its quality improvement journey, and these tools have helped us earn distinctions such as 5 stars for quality in the CMS hospital rating system; the #1 rank in the Vizient Quality and Accountability Study; and designation as a nationally recognized Honor Roll hospital by U.S. News and World Report.”

Tagged With: CMS, Health Systems, honor, Patient Experience, R1, R1 RCM, rcm, revenue cycle, Revenue Cycle Management, Value-Based Care

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |